Cadrenal Financial Statements From 2010 to 2024

Cadrenal Therapeutics, Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 5.1 M 8.5 M 1.6 M Slightly volatile Short and Long Term Debt Total 20.3 K 21.4 K 558.1 K Slightly volatile Other Current Liabilities 600.7 K 638.2 K 831 K Slightly volatile Total Current Liabilities 864.5 K 826.9 K 1.3 M Slightly volatile Other Liabilities 3.5 M 4 M 4.3 M Slightly volatile Property Plant And Equipment Net 27.2 K 23.3 K 42 K Slightly volatile Accounts Payable 228.9 K 167.3 K 377.3 K Slightly volatile Cash 4.6 M 8.4 M 897.7 K Slightly volatile Non Current Assets Total 31.1 K 27.1 K 47.7 K Slightly volatile Other Assets 4.8 K 5.4 K 5.9 K Slightly volatile Long Term Debt 442.7 K 498 K 542.3 K Slightly volatile Cash And Short Term Investments 4.6 M 8.4 M 897.7 K Slightly volatile Common Stock Shares Outstanding 904.1 K 868.2 K 790.4 K Slightly volatile Liabilities And Stockholders Equity 5.1 M 8.5 M 1.6 M Slightly volatile Capital Lease Obligations 26 K 21.4 K 41 K Slightly volatile Other Current Assets 85.2 K 89.7 K 614 K Slightly volatile Other Stockholder Equity 13.1 M 22.8 M 3.4 M Slightly volatile Total Liabilities 785.5 K 826.9 K 5.6 M Slightly volatile Property Plant And Equipment Gross 27.2 K 23.3 K 42 K Slightly volatile Short and Long Term Debt 35 K 39.4 K 42.9 K Slightly volatile Total Current Assets 5.1 M 8.5 M 1.5 M Slightly volatile Capital Stock 11.7 K 13 K 8.7 K Slightly volatile Short Term Debt 34.9 K 21.4 K 61 K Slightly volatile Common Stock 11.7 K 13 K 8.7 K Slightly volatile Property Plant Equipment 35.7 K 40.1 K 43.7 K Slightly volatile
Cadrenal Therapeutics, Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 1.8 K 2 K 1.3 K Slightly volatile Interest Expense 16.2 K 17.1 K 95 K Slightly volatile Other Operating Expenses 5.7 M 7.6 M 3.2 M Slightly volatile Research Development 2.5 M 4.1 M 776.6 K Slightly volatile Cost Of Revenue 1.8 K 2 K 1.3 K Slightly volatile Total Operating Expenses 5.7 M 7.6 M 3.2 M Slightly volatile Net Interest Income 185.6 K 208.8 K 227.4 K Slightly volatile Interest Income 199.3 K 224.2 K 244.1 K Slightly volatile Selling General Administrative 2.8 M 3.2 M 3.5 M Slightly volatile Reconciled Depreciation 1.6 K 1.8 K 1.9 K Slightly volatile
Cadrenal Therapeutics, Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Change In Cash 4.6 M 8.4 M 894.3 K Slightly volatile Net Borrowings 1.1 M 1.2 M 1.3 M Slightly volatile Change In Working Capital 137.1 K 144.3 K 545.5 K Slightly volatile Depreciation 1.8 K 2 K 1.3 K Slightly volatile Other Non Cash Items 5.2 M 4.9 M 4.6 M Slightly volatile Capital Expenditures 3.2 K 3.3 K 2.6 K Slightly volatile Change To Operating Activities 177 K 199.2 K 216.9 K Slightly volatile Total Cash From Financing Activities 7.2 M 11.9 M 2.3 M Slightly volatile End Period Cash Flow 4.6 M 8.4 M 897.7 K Slightly volatile Change To Netincome 4.2 M 4.7 M 5.2 M Slightly volatile Change To Liabilities 353.4 K 397.5 K 432.9 K Slightly volatile Stock Based Compensation 568.3 K 639.3 K 696.2 K Slightly volatile Issuance Of Capital Stock 9.5 M 10.7 M 11.7 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Capex To Depreciation 1.31 1.48 1.6103 Slightly volatile Payables Turnover 0.006 0.0118 0.0039 Slightly volatile Cash Per Share 10.16 9.6783 1.359 Slightly volatile Days Payables Outstanding 29.3 K 30.8 K 105.2 K Slightly volatile Income Quality 0.24 0.4224 0.1997 Slightly volatile Current Ratio 10.78 10.2702 1.8759 Slightly volatile Graham Number 32.46 43.8066 37.4421 Very volatile Capex Per Share 0.003 0.0034 0.0037 Slightly volatile Interest Debt Per Share 0.0421 0.0443 0.8413 Slightly volatile Debt To Assets 0.0024 0.0025 0.7139 Slightly volatile Days Of Payables Outstanding 29.3 K 30.8 K 105.2 K Slightly volatile Ebt Per Ebit 1.97 1.0949 2.3582 Slightly volatile Quick Ratio 10.78 10.2702 1.8759 Slightly volatile Cash Ratio 10.67 10.1618 1.4099 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.8 0.9 0.9808 Slightly volatile Debt Ratio 0.0024 0.0025 0.7139 Slightly volatile
Cadrenal Therapeutics, Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 38.3 M 43.1 M 47 M Slightly volatile Enterprise Value 38.8 M 43.7 M 47.6 M Slightly volatile

Cadrenal Fundamental Market Drivers

Cadrenal Upcoming Events

About Cadrenal Therapeutics, Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cadrenal Therapeutics, is a strong investment it is important to analyze Cadrenal Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cadrenal Therapeutics,'s future performance. For an informed investment choice regarding Cadrenal Stock, refer to the following important reports:

How To Invest In Cadrenal Details

Is Cadrenal Stock a good investment? Details

What is Cadrenal Therapeutics,'s Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details